![clincloud](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_03-min-1024x1024.jpg)
December 2, 2021
Phase 1 Clinical Trial Data Indicate IGCÃ’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
Facebook
Twitter
LinkedIn